AL
NVDA icon

Aspiriant LLC’s NVIDIA NVDA Stock Holding History

Aspiriant LLC’s Portfolio NVDA Stock Details NVDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.3M Sell
47,584
-2,272
-5% -$417K 0.24% 50
2025
Q4 		$9.3M Buy
49,856
+25,314
+103% +$4.71M 0.27% 47
2025
Q3 		$4.58M Sell
24,542
-1,296
-5% -$226K 0.14% 67
2025
Q2 		$4.08M Buy
25,838
+30
+0.1% +$3.77K 0.13% 75
2025
Q1 		$2.8M Buy
25,808
+2,332
+10% +$296K 0.1% 80
2024
Q4 		$3.15M Buy
23,476
+1,518
+7% +$209K 0.11% 76
2024
Q3 		$2.67M Buy
21,958
+2,523
+13% +$298K 0.1% 83
2024
Q2 		$2.4M Sell
19,435
-5,905
-23% -$597K 0.1% 85
2024
Q1 		$2.29M Buy
25,340
+2,670
+12% +$194K 0.09% 93
2023
Q4 		$1.12M Buy
22,670
+2,470
+12% +$114K 0.05% 137
2023
Q3 		$879K Buy
20,200
+2,480
+14% +$111K 0.05% 143
2023
Q2 		$750K Sell
17,720
-1,950
-10% -$64.7K 0.04% 150
2023
Q1 		$546K Buy
19,670
+1,430
+8% +$30.9K 0.03% 169
2022
Q4 		$267K Sell
18,240
-12,140
-40% -$178K 0.01% 228
2022
Q3 		$369K Buy
30,380
+790
+3% +$12.5K 0.02% 189
2022
Q2 		$448K Buy
29,590
+11,840
+67% +$223K 0.02% 172
2022
Q1 		$486K Sell
17,750
-480
-3% -$12K 0.03% 176
2021
Q4 		$537K Buy
18,230
+3,540
+24% +$97.4K 0.03% 174
2021
Q3 		$304K Buy
14,690
+3,890
+36% +$80.8K 0.02% 196
2021
Q2 		$216K Buy
+10,800
New +$173K 0.01% 225
2017
Q3 		– Sell
-70,920
Closed -$256K – 214
2017
Q2 		$256K Buy
+70,920
New +$225K 0.02% 186

Other funds holding NVDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aspiriant LLC's NVDA Position: Q1 2026 in Review

Aspiriant LLC reduced its NVIDIA (NVDA) stake by 4.6% in Q1 2026, selling an estimated $417K and leaving 47,584 shares worth $8.3M. The position accounts for 0.24% of the portfolio, ranked #50.

Aspiriant LLC first reported a position in NVDA in Q2 2017 and has held it in 21 quarters since. The position peaked at $9.3M in Q4 2025. 5,826 funds tracked by Wall St. Rank hold NVDA as of Q1 2026.

  • Aspiriant LLC held 47,584 shares of NVIDIA worth $8.3M as of Q1 2026.
  • Aspiriant LLC sold 2,272 NVIDIA shares in Q1 2026, an estimated $417K.
  • NVIDIA made up 0.24% of Aspiriant LLC's portfolio in Q1 2026, its #50 holding.
  • Aspiriant LLC first reported a position in NVIDIA in Q2 2017 and has held it in 21 quarters since.
  • Aspiriant LLC's NVIDIA position peaked at $9.3M in Q4 2025.
  • 5,826 funds tracked by Wall St. Rank held NVIDIA as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.